• BMB Reports
• /
• 제55권6호
• /
• pp.267-274
• /
• 2022

Molecular imaging is used to improve the disease diagnosis, prognosis, monitoring of treatment in living subjects. Numerous molecular targets have been developed for various cellular and molecular processes in genetic, metabolic, proteomic, and cellular biologic level. Molecular imaging modalities such as Optical Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Computed Tomography (CT) can be used to visualize anatomic, genetic, biochemical, and physiologic changes in vivo. For in vivo cell imaging, certain cells such as cancer cells, immune cells, stem cells could be labeled by direct and indirect labeling methods to monitor cell migration, cell activity, and cell effects in cell-based therapy. In case of cancer, it could be used to investigate biological processes such as cancer metastasis and to analyze the drug treatment process. In addition, transplanted stem cells and immune cells in cell-based therapy could be visualized and tracked to confirm the fate, activity, and function of cells. In conventional molecular imaging, cells can be monitored in vivo in bulk non-invasively with optical imaging, MRI, PET, and SPECT imaging. However, single cell imaging in vivo has been a great challenge due to an extremely high sensitive detection of single cell. Recently, there has been great attention for in vivo single cell imaging due to the development of single cell study. In vivo single imaging could analyze the survival or death, movement direction, and characteristics of a single cell in live subjects. In this article, we reviewed basic principle of in vivo molecular imaging and introduced recent studies for in vivo single cell imaging based on the concept of in vivo molecular imaging.

• 대한유전성대사질환학회지
• /
• 제14권2호
• /
• pp.182-185
• /
• 2014

GM1 gangliosidosis is a rare autosomal recessively inherited metabolic disease due to deficiency of ${\beta}$-galactosidase caused by mutations in the GLB1 gene. There have been three clinical subgroups in GM1 gangliosidosis, however it is difficult to differentiate because there is considerable overlap between classical phenotypes and clinical and imaging findings among the subgroups. Here, we report a Korean girl with type 2 GM1 gangliosidosis, who showed dysostosis multiplex and progressive neurological deterioration. Developmental regression was first noted at the age of 9 months, and she was diagnosed as GM1 gangliosidosis by ${\beta}$-galactosidase enzyme analysis and GLB1 mutation analysis at the age of 16 months.

• Investigative Magnetic Resonance Imaging
• /
• 제3권1호
• /
• pp.47-52
• /
• 1999

목적 : 시각자극을 이용하여 대뇌 후두엽에서 BOLD(blood oxygen level dependent)효과에 의한 기능적 자기공명영상과 양성자 자기공명분광법을 이용한 대사물질영상( metabolic i image)을 얻어 그 결과를 평가하고자 하였다. 대상 및 방법 : 24세에서 30세 사이의 8명의 남자와 2명의 여자를 포함하는 10명의 정상 성인 남녀를 대상으로 1.5T MRI에서 시각 지극을 이용하여 echo planar imaging펠스시퀀스를 사용하여 BOLD효과에 의한 영상들을 대뇌 후두엽에서 얻었다. 시각자극은 8Hz의 red flicker를 이용한 광 자극을 주였다. MR에서 얻어진 영상들을 workstation으로 전송한 뒤 자체 개발한 분석프로그램을 사용하여 상관계수방법을 이용하여 기능적 영상을 구하였다. 그리고 얻어진 영상의 활성화 부위를 선정한 뒤 양성자 자기공명 분광법을 사용하여 시각 자극에 의한 뇌 활성화시 대사물질의 변화를 분석했다. 그 후 자가공명분광영상법(magnetic resonance spectro-scopic imaging)를 실행하여 젖산(lactate)의 대사물질 영상을 얻었다. 결과 : 시각 자극에 따른 BOLD효과에 의한 뚜렷한 활성화 부위가 후두염 대뇌피질에 나타났다. 또한 이들 활성화 부위에서 자기공명분광법을 시행한 결과 휴식상태와 시각자극상태에서 NAA(N-acetyle aspartate)/Cr(creatine)이 $1.79{\pm}0.28$에서 $1.88{\pm}O.20$으로 거의 변화가 없는 것에 반해 lactate는 자극 전후 $9.48{\pm}4.38$배로 증가하였으며 이를 바탕으로 lactate에 대한 대사물질영상을 얻을 수 있었다. 결론 : 시각자극에 의한 뇌 활성화시 BOLD효과를 이용한 자기공명영상볍으로 활성화 부위를 확인할 수 있었고, 같은 부위에서 자기공명분광법을 이용하여 lactate의 증가를 확인하였다. 또한 lactate의 증가를 대사물질영상으로 표현함으로써 두 결과에 대한 상관관계 및 뇌 기능적영상에 대한 신뢰성을 높일 수 있게 되었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권5호
• /
• pp.1713-1718
• /
• 2012

Advanced imaging approaches (computed tomography, CT; magnetic resonance imaging, MRI; $^{18}F$-fluorodeoxyglucose positron emission tomography, FDG PET) have increased roles in cervical cancer staging and management. The recent FIGO (International Federation of Gynecology and Obstetrics) recommendations encouraged applications to assess the clinical extension of tumors rather than relying on clinical examinations and traditional non-cross sectional investigations. MRI appears to be better than CT for primary tumors and adjacent soft tissue involvement in the pelvis. FDG-PET/CT has increased in usage with a particular benefit for whole body evaluation of tumor metabolic activity. The potential benefits of advanced imaging are assisting selection of treatment based upon actual disease extent, to adequately treat a tumor with minimal normal tissue complications, and to predict the treatment outcomes. Furthermore, sophisticated external radiation treatment and brachytherapy absolutely require advanced imaging for target localization and radiation dose calculation.

• Journal of Korean Neurosurgical Society
• /
• 제29권12호
• /
• pp.1606-1611
• /
• 2000

Objective : To obtain more reliable sample in stereotactic biopsy, authors adopted proton chemical shift imaging ($^1H$-CSI)-directed biopsy. Until now, proton single voxel spectroscopy($^1H$-SVS) technique has been reported as a technique using metabolic information in stereotactic biopsy. The authors performed $^1H$-CSI with a stereotactic headframe in place and evaluated the pathologic results obtained from local metabolic information through $^1H$-CSI. Methods : $^1H$ CSI-directed stereotactic biopsy was performed in four patients. $^1H$-CSI and conventional Gd-enhancement stereotactic MRI was done simultaneously after application of the stereotatic frame. After reconstruction of metabolic maps of NAA/Cr, Cho/Cr, and Lactate/Cr ratios, the focal areas of increased Cho/Cr ratios and decreased NAA/Cr ratios were selected for target sites in the MR images Results : There was no difficulty in performing $^1H$-CSI with the stereotactic headframe in place. In pathologic examinations, the samples taken in area of increased Cho/Cr ratios and decreased NAA/Cr ratios showed the features of increased cellularity, mitoses and cellular atypism, thus facilitated the diagnosis. The pathologic samples taken from the area of increased Lactate/Cr ratios showed prominent feature of necrosis. Conclusion : $^1H$-CSI was feasible with stereotactic head frame in place. The final pathologic results obtained in our samples were concordant with the local metabolic informations from $^1H$-CSI. Authors believe that $^1H$ CSI-directed stereotactic biopsy may provide us advantages in obtaining more reliable tissue specimen in stereotactic biopsy.

• 대한임상검사과학회지
• /
• 제36권2호
• /
• pp.193-198
• /
• 2004

PET/CT combines the functional information from a positron emission tomography (PET) exam with the anatomical information from a computed tomography (CT) exam into one single exam. A CT scan uses a combination of x-rays and computers to give the radiologist a non-invasive way to see inside your body. One advantage of CT is its ability to rapidly acquire two-dimensional pictures of your anatomy. Using a computer these 2-D images can be presented in 3-D for in-depth clinical evaluation. A PET scan detects changes in the cellular function - how your cells are utilizing nutrients like sugar and oxygen. Since these functional changes take place before physical changes occur, PET can provide information that enables your physician to make an early diagnosis. The PET exam pinpoints metabolic activity in cells and the CT exam provides an anatomical reference. When these two scans are fused together, your physician can view metabolic changes in the proper anatomical context of your body. PET/CT offers significant advantages including more accurate localization of functional abnormalities, and the distinction of pathological from normal physiological uptake, and improvements in monitoring treatment. A PET/CT scan allows physicians to measure the body's abnormal molecular cell activity to detect cancer (such as breast cancer, lung cancer, colorectal cancer, lymphoma, melanoma and other skin cancers), brain disorders (such as Alzheimer's disease, Parkinson's disease, and epilepsy), and heart disease (such as coronary artery disease).

• 대한핵의학회지
• /
• 제36권1호
• /
• pp.19-27
• /
• 2002

The annual incidence of primary brain tumors is 7-19 cases per 100,000 people. The unique capacity of visualizing biochemical processes allows PET to determine functional metabolic activities of the brain tumors. Like other malignant tumors, F-18 FDG has been used commonly in the imaging of brain tumors. FDG PET is valuable in grading malignancy, predicting prognosis, monitoring treatment, differentiating tumor recurrence from radiation necrosis, and detecting primary lesion in metastatric brain tumors. Among amino acids labeled with positron emitters, C-11 methionine is used clinically. Tumor delineation is much better with methionine PET than with FDG PET. Low grade gliomas, in particular, are better evaluated with methionine than with FDG. PET opens another dimension in brain tumor imaging. PET imaging has clearly entered the clinical area with a profound impact on patient care in many indications.

• 한국자기공명학회논문지
• /
• 제19권3호
• /
• pp.124-131
• /
• 2015

Hyperpolarization methods are the most emerging techniques in the field of magnetic resonance (MR) researches since they make a contribution to overcoming sensitivity limitation of MR spectroscopy and imaging, leading to new fields of researches, real-time in vivo metabolic/molecular imaging and MR analysis of chemical/biological reactions in non-equilibrium conditions. Make use of enormous signal enrichments, it becomes feasible to investigate various chemical and biochemical systems with low ${\gamma}$ nuclei in real-time. This review deals with the theoretical principals of common hyperpolarization methods and their experimental features. In addition, more detailed theories, mechanisms, and applications of dissolution dynamic nuclear polarization (D-DNP) are discussed.

• Imaging Science in Dentistry
• /
• 제36권2호
• /
• pp.111-116
• /
• 2006

PET/CT is a new imaging technology that combines high-quality Positron Emission Tomography (PET) and Computed Tomography (CT). This imaging provides simultaneous anatomical and metabolic information. Therefore PET/CT is useful diagnostic modality for early detection of malignant tumor, accurate staging, decision on therapeutic plan, monitoring response to therapy and rapid detection of recurrence. We report oral and maxillofacial cancers diagnosed by using PET/CT and the usefulness of PET/CT in the evaluation of postoperative recurrence.

• 한국정보처리학회:학술대회논문집
• /
• 한국정보처리학회 2017년도 춘계학술발표대회
• /
• pp.609-610
• /
• 2017

국내 외에서 잘못된 생활습관으로 대사증후군 환자가 급증하고 있다. 최근 대사증후군 환자들을 위한 웨어러블 디바이스를 이용하여 생활습관정보를 수집 분석하여 피드백하는 연구가 진행되고 있다. 생활습관 정보를 수집하는 대표적인 방법은 온라인/오프라인 설문지 또는 웨어러블 디바이스를 활용하여 수집하는 형태로 구분된다. 그러나 기존 설문지 방법은 연속적인 데이터를 얻기 어렵고, 웨어러블 디바이스를 이용하는 방법은 신뢰성 있는 데이터를 수집하기에는 한계가 있다. 따라서 본 논문에서는 대사증후군 환자를 대상으로 생활습관 정보 수집을 위한 병원의 설문지를 앱을 기반으로 개발하여 수집하고 스마트 폰과 밴드와 같은 웨어러블 디바이스를 이용하여 실시간 활동정보를 수집하여 환자 생활 습관에 따른 맞춤 별 예방정보를 제공하는 시스템을 제안하고자 한다.